Redhill Biopharma
RDHL
S$1.91
Share price
-9.20%
Change (1 day)
-85.55%
Change (1 year)
Categories
EPS for Redhill Biopharma (RDHL)
EPS in 2023 (TTM): S-$1,016
According to Redhill Biopharma's latest financial reports the company's current EPS (TTM) is S-$901.28. In 2017 the company made an earnings per share (EPS) of S-$3,219 a decrease over its 2016 EPS that were of S-$2,833.
EPS history for Redhill Biopharma from 2013 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | S-$1,016 | |
| 2017 | S-$3,219 | 13.64% |
| 2016 | S-$2,833 | 9.12% |
| 2015 | S-$2,596 | 68.01% |
| 2014 | S-$1,545 | -25.93% |
| 2013 | S-$2,086 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Sanofi SNY | S$3.67 | -100.41% | 🇫🇷 France |
 Merck MRK | S$8.88 | -100.99% | 🇺🇸 USA |
 GlaxoSmithKline GSK | S$2.01 | -100.22% | 🇬🇧 UK |
 Taro Pharmaceutical TARO | S$1.57 | -100.17% | 🇮🇱 Israel |
 Teva Pharmaceutical Industries TEVA | S-$1.47 | -99.84% | 🇮🇱 Israel |